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Abstract 
Background: Polycystic ovary syndrome (PCOS) is a common endocrine condition affecting women of reproductive age and 
characterized by chronic anovulation, hyperandrogenism, and polycystic ovaries. There are no published data on this 
syndrome in Libyan patients. Aims and objectives:  To assess the frequency of clinical and biochemical features of PCOS in 
our patient population, and to compare this with data collected in other parts of the world. Subjects and methods: A 
retrospective analysis of patient records at the endocrine clinic in Benghazi was undertaken. Patient inclusion was according 
to Rotterdam ESHRE/ASRM criteria. Clinical features, associated diseases, family history, hormone levels, and ultrasonography 
results were analyzed. Results: The mean age of the 318 PCOS patients at presentation was 25.8 years (range 15-44 years), 
and the majority (67%) were 20-29 years old at presentation. Of all patients, 57% were obese (BMI   30), 93% had oligo- / 
amenorrhea, 91% were hirsute, and 74% had ultrasound features of polycystic ovaries. Diabetes mellitus was diagnosed in 
9% of all PCOS patients and hypertension in 4%. Total serum testosterone was elevated in 26% of the patients, and serum 
prolactin was elevated in 31%. Thyroid disease was noted among 5.3% of the patients, and a history of diabetes or 
hypertension among first-degree relatives was seen in (16%) and (8%) of the patients respectively. Conclusion: Chronic 
anovulation and hirsutism are the dominant features of PCOS in our patient population. More than half were obese, and the 
prevalence of diabetes, hypertension and thyroid disease in our patients seemed to be underestimated in comparison to other 
parts of the world. 
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Introduction 
Polycystic ovarian syndrome (PCOS) affects 4-12% of 
women of reproductive age [1]. It is characterized by 
chronic anovulation and hyperandrogenism with variable 
clinical manifestations that include oligomenorrhea, 
infertility, hirsutism, and acne. Until recently, there was no 
universally accepted clinical definition for PCOS. The 2003 
Rotterdam ESHRE/ASRM-sponsored PCOS consensus 
workshop group concluded that no single diagnostic 
criterion was sufficient for a clinical diagnosis of PCOS.   
Two out of three criteria have to be met to fit the 
definition: chronic anovulation, clinical and/or biochemical 
hyperandrogenism, and polycystic ovaries [2].  However, 
ethnicity influences the extent of these signs and 
symptoms, especially with regard to hirsutism and obesity 
[3]. Therefore, the frequency of symptoms varies between 
different countries and ethnic groups. The prevalence of 
this syndrome in Libya is unknown, and its clinical and 
biochemical characteristics have not been reported so far. 
 
 Aims and objectives 
This investigation aimed to assess the frequency of 
different clinical and biochemical features of PCOS among 
Libyan patients and to compare these frequencies with 
those reported in different parts of the world. 
 
 Subjects and methods 
The records of 318 patients diagnosed with polycystic 
ovary syndrome and under regular follow up at the 
endocrine clinic in Benghazi-Libya were analyzed. Patients 
were included according to the Rotterdam ESHRE/ASRM 
criteria [2]: 1) oligo- or anovulation, 2) clinical and/or 
biochemical signs of hyperandrogenism, and 3) polycystic 
ovaries on ultrasound (PCO). If the patient met two of 
these criteria, she was included in the study after other 
etiologies were ruled out. Trans-abdominal ultrasound 
scanning (USS) was performed by expert 
ultrasonographers. PCO was defined as  the presence of 
12 or more follicles measuring 2-9 mm in diameter in each 
ovary and/or ovarian volume > 10ml. Other possible 
causes of the symptoms were excluded. Cushing’s 
syndrome was excluded by a low-dose (1 mg) overnight 
dexamethasone suppression test whenever the syndrome 
was clinically suspected. Non-classical congenital adrenal 
hyperplasia (NCAH) is excluded by measuring the morning 
level of 17-hydroxyprogesterone in the serum; levels < 2 
ng/ml are considered low enough to exclude NCAH. 
Androgen-secreting tumors were excluded by clinical 
evaluation, total testosterone level, and DHEA-S level. 
Clinical features, associated diseases, family history, 
hormonal levels, and ultrasonography results were all 
analyzed. Total testosterone was measured by 
immunoassay using the Elecsys Testosterone reagent kit 
from Roche (USA) (normal range 0.06–0.82 ng/ml). 
Prolactin was measured by immunoassay using the Elecsys 
reagent kit from Roche (USA) (normal range 6–29.9 
ng/ml). Luteinizing hormone (LH) was measured by 
immunoassay using the Elecsys LH reagent kit from Roche 
(normal range 2.4–12.6 mIU/ml). Follicular stimulating 
hormone (FSH) was measured by immunoassay using the 
Elecsys FSH reagent kit from Roche, (normal range 3.5–
12.5 mIU/ml). Thyroid stimulating hormone (TSH) was 
measured by immunoassay using the Elecsys TSH reagent 
kit from Roche, (normal range 0.27–4.2 μIU/m). 
 
Obesity and overweight were defined according to WHO 
criteria as a body mass index (BMI)  30 kg/m2 and  25 
kg/m2 respectively. Amenorrhea was defined as absence 
of cycles in the past 6 months and oligomenorrhea as 
menses >35 days. Infertility was assessed only in married 
patients and was defined as failure of spontaneous 
pregnancy after one year of marriage in the absence of 
male infertility. Diabetes mellitus (DM) was defined as 
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fasting plasma glucose >/= 126 mg/dl. Hypertension 
(HTN) was defined as blood pressure >/=140/90 mm Hg. 
 
Statistical analyses were performed using the Statistical 
Package for the Social Sciences (Windows version 11.0; 
SPSS Inc, Chicago [IL], US). Mean values are reported 
together with +/- standard deviation (SD). Differences 
between groups were tested statistically using the Chi 
square test. Differences were considered statistically 
significant if the P-value was < 0.05. 
 
 Results
Out of the 318 studied patients, 17.3% were married 
and 82.7% were single. Mean age at presentation was 
25.8 ± 5.3 years, and about 67% of the patients were 20-
29 years old. Oligomenorrhoea was noted in 85.8%, 
amenorrhea in 7.5%, while 6.6% had normal menses. 
Hirsutism was observed in 90.8%, acne in 12%, infertility 
in 40%, and galactorrhea in 8.8%.  Mean BMI was 34.3 ± 
6.6 kg/m2 (Table I); about 57% of patients were obese 
and nearly 24% were overweight. Acanthosis nigricans 
(AN) was described in 15.7%, and 6% of these patients 
were overweight, 94% were obese and 32% were very 
obese (BMI   40 kg/m2). 
 
Table-1: features of PCOS in Benghazi-Libya  
Character Mean  Percentage 
Age   25.8 ± 5.3 yrs   
Hirsutism     90.8% 
Oligomenorrhoea     85.8% 
Amenorrhea     7.5% 
Infertility     40% 
Acne     12% 
Acanthosis nigricans     15.8% 
Obesity     57% 
BMI   34.4 ± 6.6 kg/m2   
DM   9% 
HTN   4% 
Hypothyroidism   3% 
Galactorrhoea     8.8% 
Hyperprolactinemia     31% 
High Total testosterone    26.4% 
LH:FSH > 3    16% 
USS features of PCOS    74% 
 
 
The mean BMI of those with AN was 38 ± 6.4 kg/m2, 
while those without AN had BMI of 30.4 ± 6.8 kg/m2 (p 
<0.001). About 9.3% of the patients were diabetic 
according to fasting plasma glucose levels, and 17% of 
these were overweight and 83% were obese with mean 
BMI 38 ± 7.5 kg/m2. About 3.8% of patients were 
hypertensive and of these 92.3% were obese with mean 
BMI 40.95 ± 6.64 kg/m2. Most of the patients (96.5%) 
had trans-abdominal ultrasound, whereas only 2.2% and 
1.3% had either trans-vaginal or trans-rectal 
ultrasound,respectively. Ultrasonographic appearance of 
polycystic ovaries was reported in 73.9% of the patients.  
These findings were unilateral in two cases. LH was 
elevated in 16% of patients with a mean value of 12.3 ± 
8.3 mIU/ml and was slightly higher (although non 
significantly, p >0.05) in non-obese than in obese 
patients, while the ratio between LH and FSH was >2 in 
54.7% and > 3 in only 16% of patients. Total testosterone 
was elevated in 26.4% and Prolactin in 31.3%. The 
prolactin elevation was mild (< 50% of upper limit) in 
62% of the hyperprolactinemic patients. Thyroid disease 
was a coexisting diagnosis in 5.34% of the patients; most 
were hypothyroid (3%). 
About 4% of the patients had a family member 
diagnosed with PCOS and nearly 16% had a family 
member with a history of hirsutism, irregular menses, or 
infertility. Diabetes mellitus and hypertension in a first 
degree relative was reported by 16% and 8% of the 
patients, respectively. The mother was the affected family 
member in 82% of the diabetic relatives and in 88% of 
the hypertensive relatives. A family history of thyroid 
disease was elicited in nearly 4% of patients. There was 
no statistically significant difference in the clinical and 
biochemical features of PCOS between patients with 
negative (83 patients) or positive (235 patients) 
ultrasound features for PCO (Table-2). 
 
Table-2: Comparison between patients with positive and 
negative trans-abdominal ultrasound feature of PCOS.
Discussion
To our knowledge, this study is the first report about 
clinical features of PCOS in Libya. The frequency of 
ultrasonographic features of polycystic ovaries (PCO) seen 
in our patients (74%) is much less than that  reported by 
others (96.7%) who used trans-vaginal ultrasound [4,5]. 
Transabdominal ultrasound is less sensitive and more 
operator dependant than trans-vaginal ultrasound [6]. 
Therefore, the 74% rate is probably an understimate. The 
underutilization of transvaginal ultrasound is due to 
cultural and religious restrictions in Muslim societies. The 
clinical and biochemical features of patients with normal 
USS did not differ from those with positive USS findings of 
polycystic ovary morphology (Table 2). The apparent 
higher rate of hirsutism and cycle disturbance in patients 
with normal USS findings is an artifact.. According to 
Rotterdam criteria, to diagnose PCOS in the absence of 
PCO, hyperandrogenism (clinical and/ or biochemical) and 
anovulatory cycle should coexist. Ethnic differences in the 
phenotypic presentation of PCOS is a well known 
phenomenon [3,7]. The frequency of Oligo-/ amenorrhea 
(93%) observed in this cohort was greater than reported 
in the USA (70%) [3], and the frequency of hirsutism 
(91%) was much higher than noted in Chinese women 
(35%) [4]. Only 12% of our patients had acne as 
compared to 45% in Chinese women [4]. Surprisingly, 
about 60% of the married patients were fertile without 
Feature 
Patients with 
PCO(235) 
Patients 
without 
PCO(83) 
P-value
All
patients 
(318) 
Hirsutism 88.9%  (209) 96.3%  (80)  0.046 
90.8% 
(289) 
Cycle 
disturbance
91% (214)  100% (83)  0.003 
93.3% 
(297) 
Mean BMI 
34.9 ± 6 
kg/m2 
33 ± 7.5kg/m2  0.91, ns
34.4 ± 
6.6kg/m2 
Obesity  56.2% (132)  59% (49)  0.72, ns
56.9% 
(181) 
Overweight 23.8% (56)  25.3% (21)  0.65, ns 24.2% (77)
High 
testosterone
25.5% (60)  28.9% (24)  0.46, ns 26.4% (84)
LH/FSH ratio 
  3 
16.2% (38)  15.6% (13)  0.97, ns 16% (51) 
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any medical intervention in contrast to only about 25% 
reported worldwide [8]. However, the overall prevalence 
of infertility could be higher because most of our patients 
were single (83%), married PCOS patients are usually 
under gynecologist care because of their initial concern of 
infertility. 
 
This study reports that obesity affects 57% of Libyan 
PCOS patients. Obesity is less common in PCOS women of 
Mediterranean descent, but more common in Hispanic, 
black, and white women with PCOS [3,9]. This high rate of 
obesity among the Libyan PCOS women may indirectly 
reflect the high prevalence of obesity in Libyan females in 
general [10,11]. Obesity in our patients was 2.5 times 
more common than in the general Libyan female 
population, which is 22.5% according to the WHO 
estimation for 2005 and similar to that in Spain [11,12]. 
 
Table-3: frequency of obesity in PCOS patients 
Weight class by BMI (kg/m2)  Percentage 
Under weight (<18.5)  ~ 1% 
Healthy (18.5-24.99)  ~ 18% 
Overweight (25-29.99)  ~ 24% 
Obese ( 30) 
Class-I obesity (30-34.9) 
Class-II obesity (35-39.9) 
Class-III obesity   (>40)     
~ 57% 
23.6% 
18.55% 
14.6%   
 
Diabetes mellitus frequency was 9% in our patients, 
which is similar to the USA but less than what is noted in 
Asian women (17%) [13,14]. However, if glucose 
tolerance tests were to be performed, the prevalence of 
type-2 DM might turn out to be higher and more patients 
would likely be found to have impaired glucose tolerance 
[15]. 
Hypertension was diagnosed in only 4% of our patients 
as compared to 12% in Tunisian patients [16]. This is a 
large difference in the prevalence rate in two population 
sharing a similar ethnic, and geographical background, 
however the Tunisian study was a prospective one which 
is more accurate than retrospective studies.  Obesity was 
clearly over-represented in both hypertensive and diabetic 
patients. Acanthosis nigricans (AN) was described in 
15.8% of patients, which resembles that reported in China 
[17]. The PCOS women with AN had significantly higher 
BMI, compared with those without AN, which is similar to 
observations from Thai study [18]. AN is a marker of 
insulin resistance, as it is a result of insulin stimulation to 
the basal layers of the epidermis [3]. The finding of 
elevated total serum testosterone in 26% of our patients 
seems to be an underestimate to the actual rate of 
biochemical hyperandrogenism because we depend on 
total serum testosterone assays rather than free 
testosterone assays (due to availability issues), and 
different commercial kits have different cut off values 
[19]. In the literature, about 30 % of women with PCOS 
had LH to FSH ratio > 3:1 and many researchers consider 
this ratio diagnostic for the syndrome [3,5]. However only 
16% of our patients had LH:FSH ratio > 3, indicating the 
low sensitivity of this test as a diagnostic tool in Libyan 
patients with PCOS. Clinical studies have repeatedly shown 
that obese PCOS women have significantly lower LH 
concentrations than their normal-weight counterparts, 
which we also observed in our patients [20]. The high 
Diabetes mellitus frequency was 9% in our patients, which 
is similar to the USA but less than what is noted in Asian 
women (17%) [13,14]. However, if glucose tolerance tests 
were to be performed, the prevalence of type-2 DM might 
turn out to be higher and more patients would likely be 
found to have impaired glucose tolerance 
[15].Hypertension was diagnosed in only 4% of our 
patients as compared to 12% in Tunisian patients [16]. 
This is a large difference in the prevalence rate in two 
population sharing a similar ethnic, and geographical 
background, however the Tunisian study was a 
prospective one which is more accurate than retrospective 
studies.  Obesity was clearly over-represented in both 
hypertensive and diabetic patients. Acanthosis nigricans 
(AN) was described in 15.8% of patients, which resembles 
that reported in China [17]. The PCOS women with AN 
had significantly higher BMI, compared with those without 
AN, which is similar to observations from Thai study [18]. 
AN is a marker of insulin resistance, as it is a result of 
insulin stimulation to the basal layers of the epidermis [3]. 
The finding of elevated total serum testosterone in 26% of 
our patients seems to be an underestimate to the actual 
rate of biochemical hyperandrogenism because we depend 
on total serum testosterone assays rather than free 
testosterone assays (due to availability issues), and 
different commercial kits have different cut off values 
[19]. In the literature, about 30 % of women with PCOS 
had LH to FSH ratio > 3:1 and many researchers consider 
this ratio diagnostic for the syndrome [3,5]. However only 
16% of our patients had LH:FSH ratio > 3, indicating the 
low sensitivity of this test as a diagnostic tool in Libyan 
patients with PCOS. Clinical studies have repeatedly shown 
that obese PCOS women have significantly lower LH 
concentrations than their normal-weight counterparts, 
which we also observed in our patients [20]. The high 
frequency of hyperprolactinemia (31%) observed in our 
patients is worth investigating by using multiple 
measurements at different time points. However, Prolactin 
was only mildly elevated (<50% of the upper limit of 
normal) in most patients (62%). Family history of diabetes 
in a first degree relative was observed in 16% of the 
patients; the mother was diabetic in 82% of the cases. 
This high prevalence of diabetes in mothers of PCOS 
patients was reported in other studies and may indirectly 
highlight the role of insulin resistance in the pathogenesis 
of PCOS [21]. Thyroid disease was reported in 5% of the 
patients, of which 3% had autoimmune hypothyroidism. 
In the literature, the prevalence of anti-thyroid antibodies 
and elevated TSH in PCOS patients was reported to be 
27% and 11%, respectively [22]. A screening for 
subclinical thyroid disease and for anti-thyroid antibodies 
is needed to define more accurately the prevalence of 
thyroid diseases in PCOS patients. Finally, despite the 
limitations of a retrospective review, this study might 
serve as a preliminary assessment of the disease profile in 
Libya. Community based studies are needed to define the 
prevalence of the syndrome and prospective well 
organized investigations are needed to define the 
frequency of each clinical and biochemical feature of the 
syndrome, particularly dysglycemia and other metabolic 
derangements. 
Conclusions and recommendations 
Hirsutism and cycle disturbances are the major clinical 
features of PCOS patients in Benghazi (> 90%). Obesity 
seems to be more prevalent in Libyan PCOS patients than 
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in other Mediterranean countries. The ratio between LH 
and FSH as a diagnostic tool had low sensitivity in the 
Libyan patients. Prevalence rates of DM, HTN, and 
hypothyroidism seem to be underestimated in our 
patients. 
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